Mark Lowrey

703 total citations
5 papers, 340 citations indexed

About

Mark Lowrey is a scholar working on Economics and Econometrics, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Mark Lowrey has authored 5 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Economics and Econometrics, 2 papers in Physiology and 2 papers in Psychiatry and Mental health. Recurrent topics in Mark Lowrey's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Dementia and Cognitive Impairment Research (2 papers) and Alzheimer's disease research and treatments (2 papers). Mark Lowrey is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Dementia and Cognitive Impairment Research (2 papers) and Alzheimer's disease research and treatments (2 papers). Mark Lowrey collaborates with scholars based in United States, Italy and France. Mark Lowrey's co-authors include Mark A. Mintun, Michael J. Pontecorvo, Anupa Arora, Carl Sadowsky, Alan Carpenter, Lee P. Adler, John Seibyl, Danna Jennings, Abhinay D. Joshi and Daniel Skovronsky and has published in prestigious journals such as Neurology, Journal of Nuclear Medicine and Alzheimer s & Dementia.

In The Last Decade

Mark Lowrey

5 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Lowrey United States	3	252	223	116	92	35	5	340
Michelle Zanette Sweden	7	229 0.9×	224 1.0×	82 0.7×	86 0.9×	35 1.0×	9	315
Krishnendu Saha United States	4	224 0.9×	198 0.9×	114 1.0×	93 1.0×	28 0.8×	9	319
Juhan Reimand Netherlands	8	190 0.8×	183 0.8×	79 0.7×	84 0.9×	33 0.9×	9	276
Allison Fero United States	3	212 0.8×	204 0.9×	104 0.9×	112 1.2×	22 0.6×	4	312
Denise Visser Netherlands	11	161 0.6×	173 0.8×	84 0.7×	95 1.0×	39 1.1×	29	294
Fiona Heeman Netherlands	9	188 0.7×	149 0.7×	113 1.0×	184 2.0×	23 0.7×	27	381
Sabrina M. Albertson United States	9	335 1.3×	235 1.1×	150 1.3×	64 0.7×	32 0.9×	19	455
Roger Lundqvist Sweden	6	283 1.1×	215 1.0×	131 1.1×	158 1.7×	38 1.1×	19	447
Andy Horng United States	4	297 1.2×	300 1.3×	159 1.4×	85 0.9×	34 1.0×	4	424
Ping Chiao United States	8	242 1.0×	266 1.2×	84 0.7×	101 1.1×	46 1.3×	19	436

Countries citing papers authored by Mark Lowrey

Since Specialization

Citations

This map shows the geographic impact of Mark Lowrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lowrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lowrey more than expected).

Fields of papers citing papers by Mark Lowrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lowrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lowrey. The network helps show where Mark Lowrey may publish in the future.

Co-authorship network of co-authors of Mark Lowrey

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Lowrey. A scholar is included among the top collaborators of Mark Lowrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Lowrey. Mark Lowrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Mahoney, Erin, et al.. (2020). Design of Phase 1/2a Study of AAV9-Based Gene Therapy for Parkinson’s Disease with Pathogenic GBA1 Mutations (PROPEL Trial) (1624). Neurology. 94(15_supplement). 2 indexed citations

2.

Pontecorvo, Michael J., Andrew Siderowf, Bruno Dubois, et al.. (2017). Effectiveness of Florbetapir PET Imaging in Changing Patient Management. Dementia and Geriatric Cognitive Disorders. 44(3-4). 129–143. 32 indexed citations

3.

Mintun, Mark A., Michael D. Devous, Michael J. Pontecorvo, et al.. (2017). [O5–01–01]: PET BIOMARKERS IN THE EXPEDITION 3 TRIAL OF PATIENTS WITH MILD AD. Alzheimer s & Dementia. 13(7S_Part_30). 3 indexed citations

4.

Pontecorvo, Michael J., Michael Grundman, Bruno Dubois, et al.. (2015). DT‐02‐03: A randomized, controlled, multicenter, international study of the impact of florbetapir (¹⁸F) PET amyloid imaging on patient management and outcome. Alzheimer s & Dementia. 11(7S_Part_7). 2 indexed citations

5.

Joshi, Abhinay D., Michael J. Pontecorvo, Alan Carpenter, et al.. (2012). Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects. Journal of Nuclear Medicine. 53(3). 378–384. 301 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact